Natixis Advisors, L.P. Vericel Corp Transaction History
Natixis Advisors, L.P.
- $53.5 Billion
- Q4 2024
A detailed history of Natixis Advisors, L.P. transactions in Vericel Corp stock. As of the latest transaction made, Natixis Advisors, L.P. holds 38,902 shares of VCEL stock, worth $2.22 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
38,902
Previous 36,338
7.06%
Holding current value
$2.22 Million
Previous $1.54 Million
39.15%
% of portfolio
0.0%
Previous 0.0%
Shares
12 transactions
Others Institutions Holding VCEL
# of Institutions
291Shares Held
50.8MCall Options Held
139KPut Options Held
68.5K-
Black Rock Inc. New York, NY8.06MShares$460 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.49MShares$199 Million0.0% of portfolio
-
Brown Capital Management LLC Baltimore, MD3.24MShares$185 Million4.21% of portfolio
-
State Street Corp Boston, MA2.4MShares$137 Million0.01% of portfolio
-
Invesco Ltd. Atlanta, GA2.24MShares$128 Million0.02% of portfolio
About Vericel Corp
- Ticker VCEL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 47,178,000
- Market Cap $2.69B
- Description
- Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies for sports medicine and severe burn care markets in the United States. The company markets autologous cell therapy products comprising MACI, an autologous cellularized scaffold product for t...